|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 120.30 EUR | +2.04% |
|
-0.17% | -8.66% |
| Jan. 15 | REDCARE PHARMACY : Berenberg reiterates its Buy rating | ZD |
| Jan. 14 | Redcare Pharmacy NV: Europe's leading online pharmacy secures its position |  |
| Capitalization | 2.45B 2.52B 2.3B 2.06B 3.61B 218B 4.05B 28.09B 10.42B 89.29B 9.45B 9.25B 394B | P/E ratio 2024 * |
-62.4x | P/E ratio 2025 * | -1,510x |
|---|---|---|---|---|---|
| Enterprise value | 2.63B 2.71B 2.47B 2.21B 3.88B 234B 4.35B 30.19B 11.2B 95.97B 10.16B 9.94B 424B | EV / Sales 2024 * |
1.11x | EV / Sales 2025 * | 0.9x |
| Free-Float |
100% | Yield 2024 * |
-
| Yield 2025 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Redcare Pharmacy NV
More recommendations
More press releases
More news
| 1 day | +2.04% | ||
| 1 week | -2.83% | ||
| Current month | -8.66% | ||
| 1 month | -19.96% | ||
| 3 months | -16.28% | ||
| 6 months | -12.89% | ||
| Current year | -8.66% |
1 week
110.70
129.70
1 month
110.70152.00
Current year
110.70135.90
1 year
95.60171.40
3 years
36.51171.40
5 years
36.51249.00
10 years
24.00249.00
| Director | Title | Age | Since |
|---|---|---|---|
Olaf Heinrich
CEO | Chief Executive Officer | 55 | 2023-07-31 |
Jasper Eenhorst
DFI | Director of Finance/CFO | 52 | 2020-01-31 |
Lode Fastré
CTO | Chief Tech/Sci/R&D Officer | - | 2024-04-16 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jérôme Cochet
BRD | Director/Board Member | 47 | 2015-12-31 |
Frank Köhler
BRD | Director/Board Member | 61 | 2005-12-31 |
Björn H. Söder
CHM | Chairman | 53 | 2021-04-20 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.46% | 0 M€ | -.--% | - | |
| 0.01% | 0 M€ | -3.35% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +2.04% | -2.83% | -6.49% | +11.18% | 2.47B | ||
| -0.70% | +1.62% | -12.56% | -55.97% | 11.67B | ||
| +2.37% | +29.58% | -46.15% | -76.92% | 10.58B | ||
| -1.80% | +1.55% | -10.63% | -52.39% | 6.9B | ||
| +0.63% | -4.07% | -17.06% | +67.16% | 5.56B | ||
| +1.31% | -2.73% | +20.12% | +21.24% | 4.62B | ||
| -0.17% | -0.67% | -14.61% | - | 4.14B | ||
| -2.95% | -0.04% | -28.36% | -28.49% | 4.04B | ||
| -0.87% | +6.73% | -9.01% | -32.69% | 2.82B | ||
| -0.04% | -6.01% | +13.77% | +78.58% | 2.75B | ||
| Average | +0.27% | +2.01% | -11.10% | -7.59% | 5.55B | |
| Weighted average by Cap. | +0.25% | +4.64% | -16.00% | -25.66% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 2.38B 2.45B 2.24B 2B 3.51B 212B 3.93B 27.3B 10.13B 86.8B 9.19B 8.99B 383B | 2.94B 3.03B 2.77B 2.47B 4.34B 262B 4.87B 33.78B 12.53B 107B 11.37B 11.12B 474B |
| Net income | -38.56M -39.68M -36.23M -32.42M -56.9M -3.43B -63.78M -443M -164M -1.41B -149M -146M -6.22B | -3.86M -3.97M -3.62M -3.24M -5.69M -343M -6.38M -44.25M -16.41M -141M -14.89M -14.57M -621M |
| Net Debt | 183M 188M 172M 154M 270M 16.27B 303M 2.1B 779M 6.68B 706M 691M 29.49B | 189M 195M 178M 159M 280M 16.85B 313M 2.17B 807M 6.91B 732M 716M 30.54B |
More financial data
* Estimated data
Employees
1,900
Sector
Drug Retailers
Calendar
2025-03-10
- Q4 2024 Earnings Release
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-01-15 | 120.30 € | +2.04% | 105,401 |
| 25-01-14 | 117.90 € | +4.43% | 142,632 |
| 25-01-13 | 112.90 € | -9.46% | 178,059 |
| 25-01-10 | 124.70 € | +0.48% | 107,179 |
| 25-01-09 | 124.10 € | +2.99% | 158,867 |
Delayed Quote Xetra, January 15, 2025 at 11:35 am EST
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
120.30EUR
Average target price
159.08EUR
Spread / Average Target
+32.24%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RDC Stock